Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 3112-3118, July 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernández-Alcoceba, R.
Right arrow Articles by Lacal, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernández-Alcoceba, R.
Right arrow Articles by Lacal, J. C.
[Cancer Research 59, 3112-3118, July 1, 1999]
© 1999 American Association for Cancer Research


Experimental Therapeutics

In Vivo Antitumor Activity of Choline Kinase Inhibitors

A Novel Target for Anticancer Drug Discovery1

Rubén Hernández-Alcoceba, Félix Fernández and Juan Carlos Lacal2

Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas, 28029 Madrid, Spain

Transformation by some oncogenes is associated with increased activity of choline kinase (ChoK), resulting in elevated constitutive levels of phosphorylcholine, a proposed second messenger required for DNA synthesis induced by growth factors. Here we describe the characterization of ChoK inhibitors with antiproliferative properties against human tumor-derived cell lines. The new molecules were tolerated in mice at doses that showed in vivo antitumor activity against human tumor xenografts derived from HT-29 and A431 cell lines implanted s.c. in nude mice. This first generation of inhibitors provides in vivo evidence that blockade of phosphorylcholine production is a valid strategy for the development of new anticancer agents, opening a new avenue for the development of antitumor drugs with a novel mechanism of action.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Soto and G. M. Carman
Regulation of the Saccharomyces cerevisiae CKI1-encoded Choline Kinase by Zinc Depletion
J. Biol. Chem., April 11, 2008; 283(15): 10079 - 10088.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Mori, K. Glunde, T. Takagi, V. Raman, and Z. M. Bhujwalla
Choline Kinase Down-regulation Increases the Effect of 5-Fluorouracil in Breast Cancer Cells
Cancer Res., December 1, 2007; 67(23): 11284 - 11290.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
V. Choubey, P. Maity, M. Guha, S. Kumar, K. Srivastava, S. K. Puri, and U. Bandyopadhyay
Inhibition of Plasmodium falciparum Choline Kinase by Hexadecyltrimethylammonium Bromide: a Possible Antimalarial Mechanism
Antimicrob. Agents Chemother., February 1, 2007; 51(2): 696 - 706.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. M.S. Al-Saffar, H. Troy, A. R. de Molina, L. E. Jackson, B. Madhu, J. R. Griffiths, M. O. Leach, P. Workman, J. C. Lacal, I. R. Judson, et al.
Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Choline Kinase Inhibitor MN58b in Human Carcinoma Models
Cancer Res., January 1, 2006; 66(1): 427 - 434.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Glunde, V. Raman, N. Mori, and Z. M. Bhujwalla
RNA Interference-Mediated Choline Kinase Suppression in Breast Cancer Cells Induces Differentiation and Reduces Proliferation
Cancer Res., December 1, 2005; 65(23): 11034 - 11043.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-G. Choi, V. Kurnov, M. C. Kersting, A. Sreenivas, and G. M. Carman
Phosphorylation of the Yeast Choline Kinase by Protein Kinase C: IDENTIFICATION OF Ser25 AND Ser30 AS MAJOR SITES OF PHOSPHORYLATION
J. Biol. Chem., July 15, 2005; 280(28): 26105 - 26112.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ramirez de Molina, D. Gallego-Ortega, J. Sarmentero, M. Banez-Coronel, Y. Martin-Cantalejo, and J. C. Lacal
Choline Kinase Is a Novel Oncogene that Potentiates RhoA-Induced Carcinogenesis
Cancer Res., July 1, 2005; 65(13): 5647 - 5653.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. R. de Molina, M. Banez-Coronel, R. Gutierrez, A. Rodriguez-Gonzalez, D. Olmeda, D. Megias, and J. C. Lacal
Choline Kinase Activation Is a Critical Requirement for the Proliferation of Primary Human Mammary Epithelial Cells and Breast Tumor Progression
Cancer Res., September 15, 2004; 64(18): 6732 - 6739.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yu, A. Sreenivas, D. B. Ostrander, and G. M. Carman
Phosphorylation of Saccharomyces cerevisiae Choline Kinase on Ser30 and Ser85 by Protein Kinase A Regulates Phosphatidylcholine Synthesis by the CDP-choline Pathway
J. Biol. Chem., September 13, 2002; 277(38): 34978 - 34986.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Katz-Brull, D. Seger, D. Rivenson-Segal, E. Rushkin, and H. Degani
Metabolic Markers of Breast Cancer: Enhanced Choline Metabolism and Reduced Choline-Ether-Phospholipid Synthesis
Cancer Res., April 1, 2002; 62(7): 1966 - 1970.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.